Jianhua Li

1.1k total citations · 1 hit paper
31 papers, 873 citations indexed

About

Jianhua Li is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Jianhua Li has authored 31 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 12 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Jianhua Li's work include Spine and Intervertebral Disc Pathology (4 papers), Cancer-related molecular mechanisms research (3 papers) and Circular RNAs in diseases (3 papers). Jianhua Li is often cited by papers focused on Spine and Intervertebral Disc Pathology (4 papers), Cancer-related molecular mechanisms research (3 papers) and Circular RNAs in diseases (3 papers). Jianhua Li collaborates with scholars based in China, United States and United Kingdom. Jianhua Li's co-authors include Changxing Li, Peifeng Wu, Muhammad Saeed, Dongfang Dai, Rai Muhammad Amir, Mohib Ullah Kakar, Muhammad Naveed, Qinyuan Li, Shahid Ali Rajput and Muhammad Sajjad Khan and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Toxicological Sciences and BioMed Research International.

In The Last Decade

Jianhua Li

29 papers receiving 866 citations

Hit Papers

Resveratrol (RV): A pharmacological review and call for f... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianhua Li China 16 320 173 119 108 85 31 873
Yun Chen Taiwan 19 509 1.6× 74 0.4× 122 1.0× 170 1.6× 96 1.1× 65 1.2k
Sara Elis Bianchi Brazil 17 224 0.7× 134 0.8× 97 0.8× 61 0.6× 27 0.3× 58 836
Xudong Song China 15 352 1.1× 112 0.6× 123 1.0× 63 0.6× 23 0.3× 30 731
Dong Hwan Kim South Korea 24 582 1.8× 198 1.1× 160 1.3× 65 0.6× 41 0.5× 69 1.5k
Xinwei Liu China 18 317 1.0× 86 0.5× 100 0.8× 40 0.4× 39 0.5× 63 853
Na Xu China 17 309 1.0× 200 1.2× 58 0.5× 58 0.5× 32 0.4× 55 1.1k
Yanan Liu China 15 269 0.8× 71 0.4× 47 0.4× 36 0.3× 74 0.9× 27 745
Claudia Gherman Romania 15 428 1.3× 143 0.8× 173 1.5× 20 0.2× 114 1.3× 61 1.1k
Yang Ruan China 19 426 1.3× 58 0.3× 174 1.5× 68 0.6× 19 0.2× 28 1.1k
Yung‐Hsin Cheng Taiwan 17 241 0.8× 51 0.3× 36 0.3× 60 0.6× 99 1.2× 22 959

Countries citing papers authored by Jianhua Li

Since Specialization
Citations

This map shows the geographic impact of Jianhua Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianhua Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianhua Li more than expected).

Fields of papers citing papers by Jianhua Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianhua Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianhua Li. The network helps show where Jianhua Li may publish in the future.

Co-authorship network of co-authors of Jianhua Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jianhua Li. A scholar is included among the top collaborators of Jianhua Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianhua Li. Jianhua Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Yang, Mengru, Tianyi Xia, Ying Chen, et al.. (2023). Physalis alkekengi L. var. franchetii combined with hormone therapy for atopic dermatitis. Biomedicine & Pharmacotherapy. 162. 114622–114622. 4 indexed citations
4.
Pan, Dayu, Xiaojing Wu, Jianhua Li, et al.. (2022). Silencing ATF3 Might Delay TBHP‐Induced Intervertebral Disc Degeneration by Repressing NPC Ferroptosis, Apoptosis, and ECM Degradation. Oxidative Medicine and Cellular Longevity. 2022(1). 4235126–4235126. 41 indexed citations
5.
Jiang, Yulin, Kun Shi, Miaomiao He, et al.. (2022). 3D-printed auxetic-structured intervertebral disc implant for potential treatment of lumbar herniated disc. Bioactive Materials. 20. 528–538. 76 indexed citations
6.
Zhu, Junjie, Jianhua Li, Jie Lu, et al.. (2021). Targeting Xenobiotic Nuclear Receptors PXR and CAR to Prevent Cobicistat Hepatotoxicity. Toxicological Sciences. 181(1). 58–67. 14 indexed citations
7.
Guo, Junxia, Jianhua Li, Junbiao Zhang, et al.. (2021). LncRNA PVT1 knockdown alleviated ox-LDL-induced vascular endothelial cell injury and atherosclerosis by miR-153-3p/GRB2 axis via ERK/p38 pathway. Nutrition Metabolism and Cardiovascular Diseases. 31(12). 3508–3521. 24 indexed citations
8.
Li, Hao, Lijun Tian, Jianhua Li, et al.. (2021). Construction of a Potentially Functional circRNA‐miRNA‐mRNA Network in Intervertebral Disc Degeneration by Bioinformatics Analysis. BioMed Research International. 2021(1). 8352683–8352683. 15 indexed citations
9.
Zhang, Lixue, Changxing Li, Mohib Ullah Kakar, et al.. (2021). Resveratrol (RV): A pharmacological review and call for further research. Biomedicine & Pharmacotherapy. 143. 112164–112164. 353 indexed citations breakdown →
10.
Li, Jianhua, Zahir Hussain, Junjie Zhu, et al.. (2021). Role of CYP2A6 in Methimazole Bioactivation and Hepatotoxicity. Chemical Research in Toxicology. 34(12). 2534–2539. 5 indexed citations
11.
Hu, Chunhui, Zhengsheng Liu, Jianhua Li, et al.. (2019). Enhanced Oral Bioavailability and Anti-Echinococcosis Efficacy of Albendazole Achieved by Optimizing the “Spring” and “Parachute”. Molecular Pharmaceutics. 16(12). 4978–4986. 28 indexed citations
12.
Chen, Zhigang, et al.. (2017). Downregulation of miR-200c protects cardiomyocytes from hypoxia-induced apoptosis by targeting GATA-4. International Journal of Molecular Medicine. 39(6). 1589–1596. 18 indexed citations
13.
Huang, Jianrong, Dawei Xu, Qinyue Guo, et al.. (2017). Remote Ischemic Postconditioning Improves Myocardial Dysfunction Via the Risk and Safe Pathways in a Rat Model of Severe Hemorrhagic Shock. Shock. 49(4). 460–465. 16 indexed citations
14.
Li, Jianhua, et al.. (2017). NDUFA4L2 protects against ischaemia/reperfusion‐induced cardiomyocyte apoptosis and mitochondrial dysfunction by inhibiting complex I. Clinical and Experimental Pharmacology and Physiology. 44(7). 779–786. 12 indexed citations
15.
Guo, Junxia, et al.. (2016). Knockdown of FSTL1 inhibits oxLDL-induced inflammation responses through the TLR4/MyD88/NF-κB and MAPK pathway. Biochemical and Biophysical Research Communications. 478(4). 1528–1533. 43 indexed citations
17.
Zhao, Jingjie, Xuedong Zhang, Jianwei Liu, & Jianhua Li. (2013). Primary osteosarcoma of the breast with abundant chondroid matrix and fibroblasts has a good prognosis: A case report and review of the literature. Oncology Letters. 6(3). 745–747. 7 indexed citations
18.
Li, Jianhua, et al.. (2012). In vitro study of low intensity ultrasound combined with different doses of PDT: Effects on C6 glioma cells. Oncology Letters. 5(2). 702–706. 37 indexed citations
19.
Li, Jianhua, Xianzhe Shi, Min Liu, et al.. (2005). [Methylation of hMLH1 gene promoter in gastric carcinoma with microsatellite instability].. PubMed. 24(3). 273–7. 2 indexed citations
20.
Li, Jianhua, et al.. (2002). Reversal of multidrug resistance in human K562/ADM cell line by dauricine. 24(2). 94–96. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026